Ana M C De Jesus-Acosta (Ana De Jesus-Acosta)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Radiation Therapy

Top Venues

Cancer research communications

Cancer prevention research (Philadelphia, Pa.)

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Chirayu Mohindroo, Seyda Baydogan, Parul Agarwal, Robin D Wright, Laura R Prakash, Maureen E Mork, Alison P Klein, Daniel A Laheru, Jessica E Maxwell, Matthew H G Katz, Arvind N Dasari, Michael P Kim, Jin He, Florencia McAllister, Ana M C De Jesus-Acosta
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors. Cancer prevention research (Philadelphia, Pa.) 17 (7) (2024)
Ana M C De Jesus-Acosta, Chirayu Mohindroo
Genomic Landscape of Pancreatic Neuroendocrine Tumors and Implications for Clinical Practice. JCO precision oncology 8 (2024)
Chirayu Mohindroo, Seyda Baydogan, Parul Agarwal, Robin D Wright, Laura R Prakash, Maureen E Mork, Alison P Klein, Daniel A Laheru, Jessica E Maxwell, Matthew H G Katz, Arvind N Dasari, Michael P Kim, Jin He, Florencia McAllister, Ana M C De Jesus-Acosta
Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors. Cancer prevention research (Philadelphia, Pa.) (2024)
Helen Catherine Wilbur, Jennifer N Durham, Su Jin Lim, Katrina Purtell, Katherine M Bever, Daniel A Laheru, Ana M C De Jesus-Acosta, Nilofer S Azad, Bradley Wilt, Luis A Diaz, Dung T Le, Hao Wang
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. Cancer research communications 3 (8) (2023)
Eric S Christenson, Su Jin Lim, Jennifer N Durham, Ana M C De Jesus-Acosta, Katherine M Bever, Daniel A Laheru, Amy Ryan, Parul Agarwal, Robert B Scharpf, Dung T Le, Hao Wang
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer research communications 2 (11) (2022)
Eric S Christenson, Su Jin Lim, Jennifer N Durham, Ana M C De Jesus-Acosta, Katherine M Bever, Daniel A Laheru, Amy Ryan, Parul Agarwal, Robert B Scharpf, Dung T Le, Hao Wang
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer research communications 2 (11) (2022)
Lei Zheng, Ding Ding, Barish H Edil, Carol Judkins, Jennifer N Durham, Dwayne L Thomas, Katherine M Bever, Guanglan Mo, Sara E Solt, Jessica A Hoare, Raka Bhattacharya, Qingfeng Zhu, Arsen Osipov, Beth Onner, Katrina A Purtell, Hongyan Cai, Rose Parkinson, Amy Hacker-Prietz, Joseph M Herman, Dung T Le, Nilofer S Azad, Ana M C De Jesus-Acosta, Alex B Blair, Victoria Kim, Kevin C Soares, Lindsey Manos, John L Cameron, Martin A Makary, Matthew J Weiss, Richard D Schulick, Jin He, Christopher L Wolfgang, Elizabeth D Thompson, Robert A Anders, Elizabeth Sugar, Daniel A Laheru
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)
Ludmila V Danilova, Won Jin Ho, Qingfeng Zhu, Teena Vithayathil, Ana M C De Jesus-Acosta, Nilofer S Azad, Daniel A Laheru, Elana J Fertig, Robert Anders, Elizabeth M Jaffee, Mark Yarchoan
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival. Cancer immunology research 7 (6) (2019)